Tag: Nektar
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study – BioPharma Dive
eczemarelief
February 10, 2026
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September – The Globe and Mail
eczemarelief
October 5, 2025
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher? – MarketBeat
eczemarelief
June 29, 2025
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced – BioSpace
eczemarelief
June 25, 2025